Achievements

We are conducting Open Collaboration actively to improve our research capacities

The Nasal Spray Platform Technology is an advanced drug delivery system that administers medication directly into the nasal cavity for rapid and effective absorption. This route is gaining attention for its high mucosal permeability and suitability for a wide range of therapeutics.
Daewoong Pharmaceutical is focusing on enhancing drug stability and delivery efficiency through innovative formulation design and the development of new administration routes. The company aims to become the No.1 player in nasal drug delivery formulation technology through collaborations with global experts and open innovation.

Proprietary Nasal Spray Devices and Evaluation Technology: Through joint research initiatives, Daewoong has developed its own nasal spray devices. It has also established a Technique Valuation System (TVS) that enables precise spray modeling by evaluating key parameters such as spray angle, dispersion area, and particle size.

Absorption-Enhancing Technology: Leveraging a platform based on absorption enhancers, Daewoong significantly improves the bioavailability of drugs and is developing innovative delivery technologies that enhance therapeutic efficacy.

Open Collaboration: Daewoong has built a dedicated GMP-certified manufacturing site for nasal spray products and is expanding its network of partnerships through CDMO and CMO collaborations.

Versatile Nasal Spray Product Development: Daewoong is developing a diverse portfolio of nasal spray products to meet various clinical needs. This includes multi-dose systems, single- and dual-dose precision sprays, and devices with built-in dose-counting mechanisms.